INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 125 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $124,081 | 0.0% | 151,318 | 0.0% | 0.00% | – |
| Q1 2023 | $124,081 | -47.4% | 151,318 | 0.0% | 0.00% | – |
| Q4 2022 | $236,057 | -99.9% | 151,318 | -9.9% | 0.00% | – |
| Q3 2022 | $289,774,000 | -21.4% | 167,985 | -21.1% | 0.00% | – |
| Q2 2022 | $368,507,000 | -37.1% | 213,010 | +30.6% | 0.00% | – |
| Q1 2022 | $585,467,000 | -28.1% | 163,083 | 0.0% | 0.00% | – |
| Q4 2021 | $813,784,000 | -27.6% | 163,083 | +3.8% | 0.00% | – |
| Q3 2021 | $1,124,751,000 | -23.7% | 157,088 | -1.2% | 0.00% | -100.0% |
| Q2 2021 | $1,473,170,000 | -9.0% | 158,918 | -8.9% | 0.00% | 0.0% |
| Q1 2021 | $1,619,471,000 | -5.7% | 174,512 | -10.1% | 0.00% | 0.0% |
| Q4 2020 | $1,717,076,000 | -22.5% | 194,020 | +1.6% | 0.00% | 0.0% |
| Q3 2020 | $2,215,530,000 | -43.6% | 190,994 | +31.0% | 0.00% | -50.0% |
| Q2 2020 | $3,928,529,000 | +2241.6% | 145,771 | +78.1% | 0.00% | – |
| Q3 2019 | $167,772,000 | -22.6% | 81,840 | +11.0% | 0.00% | – |
| Q2 2019 | $216,786,000 | -21.2% | 73,737 | 0.0% | 0.00% | – |
| Q1 2019 | $275,039,000 | +8.4% | 73,737 | +16.2% | 0.00% | – |
| Q4 2018 | $253,776,000 | -28.1% | 63,444 | 0.0% | 0.00% | – |
| Q3 2018 | $352,749,000 | +41.8% | 63,444 | 0.0% | 0.00% | – |
| Q2 2018 | $248,701,000 | +34.2% | 63,444 | +61.2% | 0.00% | – |
| Q1 2018 | $185,348,000 | +69.1% | 39,352 | +48.3% | 0.00% | – |
| Q4 2017 | $109,585,000 | -34.9% | 26,534 | 0.0% | 0.00% | – |
| Q3 2017 | $168,225,000 | -16.5% | 26,534 | +3.2% | 0.00% | – |
| Q2 2017 | $201,566,000 | +18.9% | 25,710 | +0.4% | 0.00% | – |
| Q1 2017 | $169,591,000 | +95175.8% | 25,618 | 0.0% | 0.00% | – |
| Q4 2016 | $178,000 | -38.6% | 25,618 | -17.6% | 0.00% | – |
| Q3 2016 | $290,000 | +1.0% | 31,100 | 0.0% | 0.00% | – |
| Q2 2016 | $287,000 | +5.9% | 31,100 | 0.0% | 0.00% | – |
| Q1 2016 | $271,000 | +29.7% | 31,100 | 0.0% | 0.00% | – |
| Q4 2015 | $209,000 | +68.5% | 31,100 | +44.7% | 0.00% | – |
| Q3 2015 | $124,000 | -53.6% | 21,500 | -34.3% | 0.00% | – |
| Q2 2015 | $267,000 | +29.6% | 32,700 | +29.8% | 0.00% | – |
| Q1 2015 | $206,000 | -4.6% | 25,200 | +7.2% | 0.00% | – |
| Q4 2014 | $216,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |